APA

Foss F. M., Ihde D. C., Breneman D. L., Phelps R. M., Fischmann A. B., Schechter G. P., Linnoila I., Breneman J. C., Cotelingam J. D. & Ghosh B. C. (19930107). Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Foss F M, Ihde D C, Breneman D L, Phelps R M, Fischmann A B, Schechter G P, Linnoila I, Breneman J C, Cotelingam J D and Ghosh B C. 19930107. Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Foss F. M., Ihde D. C., Breneman D. L., Phelps R. M., Fischmann A. B., Schechter G. P., Linnoila I., Breneman J. C., Cotelingam J. D. and Ghosh B. C. (19930107). Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Foss F M, Ihde D C, Breneman D L, Phelps R M, Fischmann A B, Schechter G P, Linnoila I, Breneman J C, Cotelingam J D and Ghosh B C. Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19930107.